Two methods, based on the use of Capillary Electrophoresis (CE) and High Performance Liquid Chromatography (HPLC), respectively, were developed for the analysis of the atypical antipsychotic aripiprazole in plasma of schizophrenic patients for therapeutic drug monitoring purposes. Good analytical performances were obtained with the CE method, using uncoated fused silica capillaries and a background electrolyte composed of 50 mM phosphate buffer at pH 2.5. With 20 kV voltage, aripiprazole was detectable at 214 nm within 5 minutes. The second analytical method, based on HPLC with diode array detection, employed a C8 reversed phase column and a mixture of a 12.5 mM phosphate buffer, pH 3.5, containing triethylamine and acetonitrile as the mobile phase. Aripiprazole was detected at 254 nm and a complete chromatographic run lasted about 10 minutes. For both analytical methods loxapine was used as the internal standard and the same plasma sample pre-treatment by means of solid-phase extraction on cyano cartridges was carried out, with extraction yield values always higher than 91.3%. Linear responses for aripiprazole were obtained between 70 and 700 ng/mL and precision assays (expressed as relative standard deviation values) were lower than 7.0%. After validation, both methods were successfully applied to human plasma samples drawn from schizophrenic patients undergoing therapy with Abilify® tablets. Accuracy was satisfactory, with recovery value higher than 91.0%.

Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high performance liquid chromatography with diode array detection

MUSENGA, ALESSANDRO;SARACINO, MARIA ADDOLORATA;SPINELLI, DOMENICO;RIZZATO, EGON;BONCOMPAGNI, GIANCARLO;RAGGI, MARIA AUGUSTA
2008

Abstract

Two methods, based on the use of Capillary Electrophoresis (CE) and High Performance Liquid Chromatography (HPLC), respectively, were developed for the analysis of the atypical antipsychotic aripiprazole in plasma of schizophrenic patients for therapeutic drug monitoring purposes. Good analytical performances were obtained with the CE method, using uncoated fused silica capillaries and a background electrolyte composed of 50 mM phosphate buffer at pH 2.5. With 20 kV voltage, aripiprazole was detectable at 214 nm within 5 minutes. The second analytical method, based on HPLC with diode array detection, employed a C8 reversed phase column and a mixture of a 12.5 mM phosphate buffer, pH 3.5, containing triethylamine and acetonitrile as the mobile phase. Aripiprazole was detected at 254 nm and a complete chromatographic run lasted about 10 minutes. For both analytical methods loxapine was used as the internal standard and the same plasma sample pre-treatment by means of solid-phase extraction on cyano cartridges was carried out, with extraction yield values always higher than 91.3%. Linear responses for aripiprazole were obtained between 70 and 700 ng/mL and precision assays (expressed as relative standard deviation values) were lower than 7.0%. After validation, both methods were successfully applied to human plasma samples drawn from schizophrenic patients undergoing therapy with Abilify® tablets. Accuracy was satisfactory, with recovery value higher than 91.0%.
A. Musenga; M.A. Saracino; D. Spinelli; E. Rizzato; G. Boncompagni; E. Kenndler; M.A. Raggi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/64137
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 34
social impact